Physical security risk management for life sciences
Your exposure is spread across labs, plants, trial sites, and a cold chain that never stops moving, and a five-point rating scale cannot tell you which one gets the next dollar. Holtium brings the whole footprint into one place, puts a dollar figure on the risk at each site, and helps your team decide what to fix first.
If your operation is hospitals and clinics rather than labs and plants, see Holtium for Healthcare.
The stakes
to bring one drug from discovery to launch, up from $2.23B the year before. That is what sits inside a lab when research is compromised.
Deloitte, Measuring the return from pharmaceutical innovation, 2025.
medical products in low- and middle-income countries is substandard or falsified, which keeps counterfeit and diversion pressure on every legitimate supply chain.
World Health Organization.
in estimated annual pharma losses to temperature excursions and improper handling, with security events at warehouses and in transit among the drivers.
IQVIA estimate.
Every site type carries a different risk, and you are asked to compare them anyway
A research lab holds years of work that has no replacement cost line. A GMP plant answers to inspectors who can stop a line. Patients, product, and data converge on a single trial site address. Organized theft groups actively target the loads a distribution hub moves. Each one is a different risk, and your budget has to cover all of them.
Most life sciences security teams manage this with site assessments in separate documents, a rating scale that calls everything medium, and spending decisions defended by judgment alone. When the CFO asks why the next dollar goes to the plant and not the lab, there is no evidence behind the answer. That is the gap this page is about.
Business risk through a physical security lens
A stolen load is a replacement cost, but a diverted one that resurfaces in the market is a brand and patient safety problem that costs far more.
Theft on pharma lanes is shifting toward fraud-based pickups and insider-enabled methods (BSI Consulting and TT Club), and the exposure sits at docks, in carrier vetting, and on high-value routes. For network-level cargo theft, see Holtium for Logistics.
Clinical trial sites, infusion centers, and patient-facing operations put your staff in the settings where workplace violence concentrates: the Bureau of Labor Statistics finds healthcare settings absorb about 73 percent of nonfatal workplace violence injuries in the US.
Each incident carries a safety response cost, and duty of care that cannot be evidenced compounds into legal exposure.
At $2.67B to bring one drug to launch (Deloitte, 2025), the research inside a lab is usually worth more than the building around it.
Physical access to labs, pilot plants, and the people who carry the work is part of how research walks out the door, and the loss shows up as competitive advantage that never appears on an incident report.
Access control, visitor management, and material handling at GMP plants and trial sites are inspection subjects, not just security hygiene.
cGMP and the EU's good distribution practice rules put facility controls in inspection scope, the Drug Supply Chain Security Act makes supply chain traceability a legal obligation, and DEA diversion control makes the secure storage and handling of controlled substances a physical security requirement with license exposure attached. A finding that stops a line or delays an approval turns a control gap into lost production time and legal exposure, in amounts that dwarf the cost of the control itself.
Industry surveys put annual pharma losses to temperature excursions and improper handling in the tens of billions.
Security events at warehouses and in transit are one driver of those excursions, and a single interrupted shipment of high-value product can be a full replacement loss plus the productivity cost of the shortage behind it.
The platform your security team runs the program on, tuned to how life sciences operates
Holtium brings your risks, controls, locations, and spending into one place, helps your team decide what to do next, and measures it all in dollars so leadership can act on it. A Holtium team works alongside yours, so you get the analysis without building it.
Your risk register covers the risks this industry actually carries: theft and diversion in the supply chain, violence at patient-facing sites, research security at labs, regulatory exposure at GMP facilities, and interruption of the cold chain. Build it in the platform, or bring in the one you already have.
Control mapping connects every control you already run, badge readers, guard posts, cameras, visitor management, cold chain monitoring, and vetted carriers, to the risks it reduces and the sites it covers, so you can see that the plant is well protected while two trial sites are carrying more exposure than anyone had written down.
The roadmap turns decisions into tasks with owners, budgets, and tracking, and the What-If simulator shows the effect of a decision before you commit a dollar to it, such as vetting carriers on a theft-prone lane versus upgrading access control at a lab, so prioritization across your footprint is an evidenced decision rather than an instinct.
A dollar figure your CFO will question, built to survive the questioning
We start with your baseline, the risk each site would face with nothing but doors, walls, and locks, then subtract what your current controls already prevent. What remains is your exposure today, broken into the losses behind it, such as replacing a stolen load, the production time an inspection finding costs, and the competitive advantage lost when research is compromised.
It is built on recognized standards and loss data, the same quantitative discipline used in cyber, operational risk, and engineering. It begins as a range rather than a false-precise figure and sharpens as we verify your controls, and every figure traces back to what drove it.
Each quarter, leadership gets an executive risk report that reads like finance: where exposure stands across the footprint, what moved it, and what comes next.
Inherent, losses avoided, and residual risk exposure, split into loss types. Life sciences sample data.
Your site assessments and control inventories are the input, not wasted work
You share what you already track, in any format: partner provider assessments, spreadsheets, guard post orders, insurance schedules. We map it to your risks and sites for you, and most teams are up and running within weeks. Your job is to review and confirm, not to do the heavy lifting.
Questions life sciences teams ask
How do you put a dollar figure on risk across labs, plants, and trial sites?
We model each risk at each lab, plant, trial site, and lane using recognized standards and loss data, the same quantitative discipline used in cyber, operational risk, and engineering. The figure starts as a range, sharpens as your controls are verified, and always traces back to what drove it, so your team can defend it in front of a CFO or a board.
Does this help with FDA and cGMP inspection readiness?
Holtium is not a compliance tool, but it keeps the evidence inspections ask about in one place: which controls exist at which sites, what condition they are in, what is on the roadmap, and which risks leadership formally accepted and why. Teams use that record to answer auditors with documentation instead of recollection.
We already have site risk assessments from a partner provider. Do we start over?
No. Existing assessments are exactly the input the platform wants. We ingest them, map the findings to risks, controls, and sites, and your team reviews and confirms. The work you have paid for becomes the starting picture instead of a drawer of PDFs.
How long until we see a risk picture across all our sites?
Most teams are up and running within weeks. You share what you already track, we structure and map it, and the first quantified picture covers your full footprint, from research labs to distribution, rather than one pilot site.
How does this cover theft and diversion on pharma lanes?
Lanes and carriers are modeled alongside your sites, so diversion risk is priced where it actually sits: at the dock, in carrier vetting, and on high-value routes. For cargo theft across a broader distribution network, see Holtium for Logistics.
See what your exposure is worth across your footprint
You stay in charge of the program. We do the analysis, so you get the evidence without building it.
